Phase II studies: untreated breast cancer patients.
Costanza
M E
ME
D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017322:Clinical Trials, Phase II as Topic; D005260:Female; D006801:Humans; D017239:Paclitaxel / Q000627:therapeutic use*
D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; C055925:anthrapyrazole; D017239:Paclitaxel